Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

242.90 -5.34 (-2.15%)
Delayed Quote Updated: 3:09 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
News headline image
6 Mid-Cap Gems for Growth at a Reasonable Price ↗
A look at 6 attractively valued mid-cap stocks that are trading at valuations that are lower than their expected long-term growth rates. 
Via Talk Markets
Agentix Corp. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021
Via AB Newswire
Topics Intellectual Property
This Could Be The Most Exciting Healthcare Development Of The Year
Via FinancialNewsMedia
Topics Artificial Intelligence Cannabis
News headline image
Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes ↗
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes. 
Via Investor's Business Daily
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Morgan Stanley boosted the price target on Applied Materials, Inc. (NASDAQ: AMAT) from $113 to $137. Applied Materials shares fell 1.1% to $123.46 in pre-market trading.... 
Via Benzinga
News headline image
Cramer Advises Viewers On Suncor, Jazz And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said that in the energy space he is recommending only Chevron Corporation (NYSE: CVX) and Pioneer Natural Resources... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More ↗
This was an eventful week for the cannabis industry. On Monday, Tilray, Inc. (NASDAQ: 
Via Benzinga
Topics Cannabis
News headline image
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio ↗
The biopharmaceutical company Jazz Pharmaceuticals, has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. 
Via Talk Markets
News headline image
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio ↗
The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH). The... 
Via Benzinga
News headline image
Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes ↗
The developer of cannabis-based medications is now under new ownership. 
Via The Motley Fool
News headline image
Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript ↗
JAZZ earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Jazz Pharma Easily Beats Earnings Views, But Sales Come In Light ↗
Late Tuesday, Jazz Pharma reported adjusted earnings of $3.92 per share on $607.58 million in sales for its first quarter. Jazz stock was unmoved. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
GW Pharmaceuticals Stockholders Approve Acquisition by Jazz Pharmaceuticals ↗
Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline. 
Via The Motley Fool
Topics Cannabis
News headline image
Alzheimer's Disease: 5 Stocks on Biotech Radars ↗
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other... 
Via Talk Markets
PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment
Via AB Newswire
Topics Cannabis Intellectual Property
News headline image
Healthcare Investors: Here's What You Need to Know About Medical Marijuana ↗
Although research on the medical benefits of the drug is limited in the U.S., we have some ideas about marijuana's ability to disrupt the healthcare industry. 
Via The Motley Fool
Topics Cannabis
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.